Publications by authors named "Katharine Cuff"

Claim this Profile
M
Management of Glioblastoma in Elderly Patients in a Single Australian Centre.
Kimberley Budgen, Danica Cossio, Danny R Youlden, Nathan Dunn, Suzanne Poulgrain, Katharine Cuff

J Med Imaging Radiat Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing a nurse-enabled, integrated, shared-care model involving specialists and general practitioners in early breast cancer post-treatment follow-up (EMINENT): a single-centre, open-label, phase 2, parallel-group, pilot, randomised, controlled trial.
Raymond J Chan, Fiona Crawford-Williams, Chad Yixian Han, Lee Jones, Alexandre Chan, Katharine Cuff

EClinicalMedicine· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telepharmacy for outpatients with cancer: An implementation evaluation of videoconsults compared to telephone consults using the CFIR 2.0.
Marissa Ryan, Elizabeth C Ward, Clare Burns, Christine Carrington, Katharine Cuff

Explor Res Clin Soc Pharm· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medicine Access Programmes: what do patients think - a patient-reported outcome study on ribociclib in metastatic breast cancer in Australia.
Natasha Yap, Vanessa Wong, Catherine Morton, Richard de Boer, Sally Baron-Hay, Katharine Cuff

Intern Med J· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitors and immune-related adverse events.
Winston Naidoo, Katharine Cuff, Marissa Ryan

Aust Prescr· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma.
Hao-Wen Sim, Luke Wachsmuth, Elizabeth H Barnes, Sonia Yip, Eng-Siew Koh, Katharine Cuff

Neurooncol Adv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NeoAdjuvant pembrolizumab and STEreotactic radiotherapy prior to nephrectomy for renal cell carcinoma (NAPSTER): A phase II randomised clinical trial.
Muhammad Ali, Simon Wood, David Pryor, Daniel Moon, Mathias Bressel, Katharine Cuff

Contemp Clin Trials Commun· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Outcomes of Ribociclib and Aromatase Inhibitor Use in First Line Hormone Receptor Positive, HER2-Negative Metastatic Breast Cancer.
Vanessa Wong, Richard de Boer, Sally Baron-Hay, Robert Blum, Frances Boyle, Katharine Cuff

Clin Breast Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An evaluation of telephone versus videoconference consults for pre-treatment medication history taking by cancer pharmacists.
Marissa Ryan, Elizabeth C Ward, Clare L Burns, Christine Carrington, Katharine Cuff

J Telemed Telecare· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma-The RAPPORT Trial.
Shankar Siva, Mathias Bressel, Simon T Wood, Mark G Shaw, Sherene Loi, Katharine E Cuff

Eur Urol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changing from telephone to videoconference for pre-treatment pharmacist consults in cancer services: Impacts to funding and time efficiency.
Marissa Ryan, Christine Carrington, Elizabeth C Ward, Clare L Burns, Katharine Cuff

J Telemed Telecare· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/II study of stereotactic radiotherapy and pembrolizumab for oligometastatic renal tumours (RAPPORT): Clinical trial protocol.
David Pryor, Mathias Bressel, Nathan Lawrentschuk, Ben Tran, Jennifer Mooi, Katharine Cuff

Contemp Clin Trials Commun· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing a nurse-enabled, integrated, shared-care model involving specialists and general practitioners in breast cancer post-treatment follow-up: a study protocol for a phase II randomised controlled trial (the EMINENT trial).
Raymond Javan Chan, Jon Emery, Katharine Cuff, Laisa Teleni, Camilla Simonsen

Trials· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating Antibodies.
Hui Yi Chew, Priscila O De Lima, Jazmina L Gonzalez Cruz, Blerida Banushi, Godwins Echejoh, Katharine Cuff

Cell· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes based on age in the phase III METEOR trial of cabozantinib versus everolimus in patients with advanced renal cell carcinoma.
Frede Donskov, Robert J Motzer, Eric Voog, Elizabeth Hovey, Carsten Grüllich, Katharine Cuff

Eur J Cancer· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SASH1 mediates sensitivity of breast cancer cells to chloropyramine and is associated with prognosis in breast cancer.
Joshua T Burgess, Emma Bolderson, Jodi M Saunus, Shu-Dong Zhang, Lynne E Reid, Katharine Cuff

Oncotarget· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synchronous breast cancer and lymphoma: a case series and a review of the literature.
Katharine E Cuff, Andrew J Dettrick, Boris Chern

J Clin Pathol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis